Smart Hemp Gummies - There are no standards in place for producing, testing or labeling CBD products, which makes any type of federal oversight or quality control impossible. CBD's classification as a Schedule I drug severely limits the amount of studies researchers can conduct on the compound.It is less processed than isolates since manufacturers retain the majority of the plant in the product. The con of broad-spectrum is that it is not widely available in the market because of its extraction process. These studies are showing promising results to hemp’s ability to naturally relieve pain. Should this receive scientific backing, it could mean a natural and safe alternative to prescription pain medication. Prof O'Sullivan points out that novelty products like CBD cappuccinos and ice-cream, often sold at a premium, have so little CBD in them that "there's just no possibility it's going to have a biological effect".